Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

974 results about "Molecular oxygen" patented technology

Molecular oxygen Molecular oxygen (O 2) is a diatomic molecule that is composed of two oxygen atoms held together by a covalent bond. ... Combustion is the reaction of a compound (the fuel) with an oxidant (which is usually molecular oxygen) to produce oxides. The third component of combustion is a "boost" of energy needed in order to start the reaction - the activation energy.

Apparatus and process for mediated electrochemical oxidation of materials

A unique apparatus unique apparatus and process that uses mediated electrochemical oxidation (MEO) for: (1) Destruction of: a) nearly all organic solid, liquid, and gases materials, except fluorinated hydrocarbons; b) all biological solid, liquid, and gases materials; c) and/or dissolution and decontamination (such as cleaning equipment and containers, etc.) of nearly all inorganic solid, liquid, or gas where higher oxidation states exist which includes, but is not limited to, halogenated inorganic compounds (except fluorinated), inorganic pesticides and herbicides, inorganic fertilizers, carbon residues, inorganic carbon compounds, mineral formations, mining tailings, inorganic salts, metals and metal compounds, etc.); and d) combined materials (e.g. a mixture of any of the foregoing with each other); henceforth collectively referred to as materials. (2) Sterilization/disinfection of equipment, glassware, etc., by destroying all existing infectious materials. (3) Dissolution of transuranic/actinide materials and/or destruction of the oxidizable components in the hazardous waste portion of mixed waste. (4) Generation of hydrogen and oxygen from MEO of materials. (5) Alteration of organic, biological, and inorganic materials by MEO to produce other compounds from these materials. The materials are introduced into an apparatus for contacting the materials with an electrolyte containing the oxidized form of one or more reversible redox couples, at least one of which is produced electrochemically by anodic oxidation at the anode of an electrochemical cell. The oxidized forms of any other redox couples present are produced either by similar anodic oxidation or reaction with the oxidized form of other redox couples present and capable of affecting the required redox reaction. The oxidized species of the redox couples oxidize the materials molecules and are themselves converted to their reduced form, whereupon they are reoxidized by either of the aforementioned mechanisms and the redox cycle continues until all oxidizable material species, including intermediate reaction products, have undergone the desired degree of oxidation. The entire process takes place at temperatures between ambient and approximately 100° C. The oxidation process may be enhanced by the addition of reaction enhancements, such as: ultrasonic energy and/or ultraviolet radiation.
Owner:SCIMIST LNC

Application of light at plural treatment sites within a tumor to increase the efficacy of light therapy

Light is administered during photodynamic therapy (PDT) for an extended period of time at a plurality of sites distributed within the abnormal tissue of a tumor. A clinical study has shown that a substantially greater volume of abnormal tissue in a tumor is destroyed by the extended administration of light therapy from a plurality of probes than would have been expected based upon the teaching of the prior art. In this process, a plurality of light emitting optical fibers or probes are deployed in a spaced-apart array. After a photoreactive agent is absorbed by the abnormal tissue, the light therapy is administered for at least three hours. The greater volume of necrosis in the tumor is achieved due to one or more concomitant effects, including: the inflammation of damaged abnormal tissue and resultant immunological response of the patient's body; the diffusion and circulation of activated photoreactive agent outside the expected fluence zone, which is believed to destroy the abnormal tissue; a retrograde thrombosis or vascular occlusion outside of the expected fluence zone; and, the collapse of the vascular system that provides oxygenated blood to portions of the tumor outside the expected fluence zone. In addition, is possible that molecular oxygen diffusing and circulating into the expected fluence zone is converted to singlet oxygen during the extended light therapy, causing a gradient of hypoxia and anoxia that destroys the abnormal tissue outside the expected fluence zone.
Owner:LIGHT SCI ONCOLOGY

Process for producing acrylonitrile or methacrylonitrile from propane or isobutane by ammoxidation

Process for producing acrylonitrile or methacrylonitrile from propane or isobutane by ammoxidation at a temperature in the range of from 380 to 500 DEG C. in a fluidized-bed reactor containing a catalyst composition preheated to a temperature of not lower than 300 DEG C. and lower than the ammoxidation reaction temperature, the catalyst composition comprising a carrier having supported thereon an oxide catalyst comprising a compound oxide of molybdenum, vanadium, niobium and at least one element selected from tellurium and antimony, wherein the ammoxidation of propane or isobutane is preceded by a specific temperature elevation operation in which the catalyst temperature in the reactor is elevated, while supplying into the fluidized-bed reactor a molecular oxygen-containing gas together with a combustible gas capable of combustion by reaction with the molecular oxygen in the presence of said catalyst composition, until the temperature of the catalyst composition reaches said ammoxidation reaction temperature. The process of the present invention is advantageous in that the temperature elevation of the catalyst can be performed without suffering a deterioration of the catalytic activity during the temperature elevation, thereby allowing the catalyst to fully exhibit its performance.
Owner:ASAHI KASEI KK
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products